Zorn, Kristin K.

Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers

Jazaeri, A. A., Awtrey, C. S., Chandramouli, G. V. R., Chuang, Y. E., Khan, J., Sotiriou, C., Aprelikova, O., Yee, C. J., Zorn, K. K., Birrer, M. J., et al. (2005) · Clinical Cancer Research

Ovarian cancer diagnosis and treatmentGene expression and cancer classification

Cited by 192

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32, 295 women

EMBRACE, Rebbeck, T. R., HEBON, Friebel, T. M., Mitra, N., Wan, F., Chen, S., Andrulis, I. L., Apostolou, P., Arnold, N., et al. (2016) · Breast Cancer Research

BRCA gene mutations in cancerMultiple and Secondary Primary Cancers

Cited by 71

Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer Is Feasible With High Completion Rates, Low Complications, and Acceptable Patient Outcomes

Skaznik-Wikiel, M. E., Lesnock, J. L., McBee, W. C., Beriwal, S., Zorn, K. K., Richard, S. D., Krivak, T. C., & Edwards, R. P. (2012) · International Journal of Gynecological Cancer

Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal Malignancies

Cited by 15